Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1/2 1

Status

Recruiting 2Not yet recruiting 2Completed 2Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Small Cell Lung Carcinoma 8Carcinoma, Non-Small-Cell Lung 7Thyroid Neoplasms 2Sarcoma 2Nasopharyngeal Carcinoma 2Lung Neoplasms 2Esophageal Squamous Cell Carcinoma 2Carcinoma, Renal Cell 2Carcinoma, Hepatocellular 2Breast Neoplasms 2Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Cancer Extensive Stage 1Proteinuria 1Platinum-resistant Ovarian Cancer (PROC) 1Pheochromocytoma 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Osteosarcoma 1Neoplasms 1Neoplasm Metastasis 1NSCLC 1Melanoma 1Limited Stage Small Cell Lung Cancer 1Fallopian Tube Neoplasms 1Extensive Stage Lung Small Cell Cancer 1Esophageal Neoplasms 1Endometrial Neoplasms 1Carcinoma, Ovarian Epithelial 1

Interventions

Cisplatin 11toripalimab 8Capecitabine 8Gemcitabine 6Fluorouracil 5tislelizumab 4Radiotherapy, Intensity-Modulated 4Radiotherapy 3sintilimab 2anlotinib 2Taxes 2Radiation 2Drug Therapy 2spartalizumab 1pembrolizumab 1palbociclib 1nedaplatin 1lobaplatin 1camrelizumab 1Valganciclovir 1Therapeutics 1Taurine 1Sodium Fluoride 1Single Person 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1Leyk 1LY-2157299 1Induction Chemotherapy 1Docosahexaenoic Acids 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Nasopharyngeal Carcinoma × anlotinib × Clear all
NCT07540390 2026-04-22

GAPP Induction and Concurrent Chemoradiotherapy for High-risk Locoregionally Advanced NPC.

Sun Yat-sen University

Phase 3 Not yet recruiting
442 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT07320963 2026-03-20

Chidamide in Combination With Toripalimab and Anlotinib in Recurrent/Metastatic Nasopharyngeal Carcinoma.

Sun Yat-sen University

Phase 1/2 Not yet recruiting
52 enrolled
Head & Neck

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡